Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Stock Symbol
-
APLS on Nasdaq
Caroline Baumal - trading volume in the past year for Apellis Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
58.4K |
$3.72M |
$63.69 |
Jan 16, 2024 |
Direct |
|
|
Stock Option (Right to Buy) |
37K |
$2.45M |
$66.30 |
Jan 16, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.